GHO Capital-backed Caprion Biosciences acquires Primity Bio
Caprion Biosciences Inc has acquired Primity Bio Inc, a Fremont, California-based provider of biomarker and immune monitoring services. Terms weren't disclosed. Caprion is a Montréal-based provider of immunology and proteomics laboratory services to the pharmaceutical and biotechnology industry. It said the buy will expand its immunology and molecular profiling service offering and give the company an operational location in the United States. The add-on deal is Caprion's second since it was acquired two years ago by U.K. healthcare private equity firm GHO Capital Partners. GHO bought the business from Chicago Growth Partners.
22 August 2018•4 mins read
